SCHEMBL7101983

SCHEMBL7101983

CCCCC/C=C(/C(=O)OCC)c1csc(N)n1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.54
MAPT P10636 4/20 0.54
MEN1 O00255 4/20 0.54
KMT2A Q03164 4/20 0.54
RAB9A P51151 2/20 0.54
NPC1 O15118 1/20 0.54
TDP1 Q9NUW8 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
MAPK1 P28482 2/20 0.40
LMNA P02545 1/20 0.40
TSHR P16473 2/20 0.39
FAAH O00519 2/20 0.37
HTT P42858 2/20 0.37
GAA P10253 2/20 0.37
KDM4E B2RXH2 1/20 0.37
PKM P14618 1/20 0.37
POLB P06746 1/20 0.37
ITGB1 P05556 1/20 0.37
ITGA4 P13612 1/20 0.37
CYP1A2 P05177 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7101990 1.00 ALDH1A1 (0.54) ALDH1A1MAPTMEN1KMT2ARAB9A
SCHEMBL7103320 0.96 ALDH1A1 (0.56) ALDH1A1MAPTMEN1KMT2ARAB9A
SCHEMBL27456772 0.96 ALDH1A1 (0.56) ALDH1A1MAPTMEN1KMT2ARAB9A
SCHEMBL7103317 0.96 ALDH1A1 (0.56) ALDH1A1MAPTMEN1KMT2ARAB9A
SCHEMBL7107479 0.92 MEN1 (0.47) ALDH1A1MAPTMEN1KMT2ARAB9A
SCHEMBL7107481 0.92 MEN1 (0.47) ALDH1A1MAPTMEN1KMT2ARAB9A
SCHEMBL7104365 0.92 MAPT (0.47) ALDH1A1MAPTMEN1KMT2ARAB9A
SCHEMBL7103310 0.92 MEN1 (0.47) ALDH1A1MAPTMEN1KMT2ARAB9A
SCHEMBL7103308 0.92 MEN1 (0.47) ALDH1A1MAPTMEN1KMT2ARAB9A
SCHEMBL7104362 0.92 MAPT (0.47) ALDH1A1MAPTMEN1KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1000939-B1 Producing z-isomer of hydrogen bromide salt of 2-aminothiazole derivative SUMITOMO CHEMICAL CO (JP) 2003-09-17 EP disclosed
US-6403572-B1 REACTING ACID SALT OF A 2-AMINOTHIAZOLE COMPOUND WITH INORGANIC ACID SUMITOMO CHEMICAL CO., LTD. (JP) 2002-06-11 US disclosed
US-20020058818-A1 Producing Z-isomer of hydrogen bromide salt of 2-aminothiazole derivative SUMITOMO CHEMICAL CO., LTD. 2002-05-16 US disclosed
US-6340763-B1 SALT FORMATION AND CRYSTALLIZATION, REACTION OF HALOGENATED COMPOUND AND THIOUREA COMPOUND SUMITOMO CHEMICAL CO., LTD. (JP) 2002-01-22 US disclosed
EP-1000939-A1 Producing z-isomer of hydrogen bromide salt of 2-aminothiazole derivative SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2000-05-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020058818-A1 Producing Z-isomer of hydrogen bromide salt of 2-aminothiazole derivative ZYX, H1-0, HAO2 ALDH1A1 2333/4885MAPT 1584/4885MEN1 2308/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.